Medidata Partner, Click Therapeutics, Announces FDA Marketing Authorization for CT-132, the First Prescription Digital Therapeutic for the Preventive Treatment of Episodic Migraine in the United States
Digital Therapeutics (DTx) – Medidata and Click advance software-based treatments
Medidata and Click Therapeutics represents the industry-leading partnership to advance of digital therapeutics (DTx) — not just in clinical trials, but across the entire patient journey, from study participation to ongoing care.
Together, this partnership creates the first end-to-end offering that unifies clinical research and software-based treatments to support the development of Prescription Digital Therapeutics (PDTs) and Software-Enhanced (SE) drugs, setting a new gold standard in patient-centric care.
Advancing Novel Digital Treatments with Medidata & Click Therapeutics Partnership
Download the factsheet to learn more about how the partnership can drive meaningful advancements in patient care with digital interventions developed and validated through Click’s scientific rigor and Mediata’s clinical trial platform.
Dassault Systèmes Intensifies the MEDIDATA Commitment to Patient Experience with Investment in Click Therapeutics for Digital Therapeutics beyond Clinical Trials
Improving patient engagement – post-trial through commercialization – and advancing the Patient Experience to deliver end-to-end technology solutions across the healthcare ecosystem.
Partners-of-Choice to Digitize Your Pharma Pipeline
The unified expertise of Click Therapeutics and Medidata drive the discovery, development, and clinical validation of your advanced novel digital treatments.
Develop: Click Therapeutics
Deep Development Expertise
Deep Expertise in developing clinically validated, FDA-regulated Prescription Digital Therapeutics.
Trusted Pharma Partner-of-choice
Rich history of successful partnerships with Phama in developing regulated digital treatment solutions.
Validate: Medidata
Single Patient Portal
Empowers patients to join, enroll, and participate in clinical trials from anywhere on any device.
Unified platform
Streamlines end-to-end clinical trial processes and data flow at scale, from consent to data capture to reimbursement.
The Time is Now for Software Based Treatments
Medidata and Click Therapeutics are streamlining software-based treatments to market with confidence, backed by decades of proven success in clinical trial execution and DTx development across a wide range of therapeutic areas.
Medicine Just Got a Digital Upgrade
Combine software with pharmacotherapy to create Software-Enhanced Drug™ treatment options, targeting the unique needs of a specific medication to deliver added clinical benefit to patients.
Evidence-based, high-impact software as medicine.
Click’s platform can target any disease, symptom or side effect with an underlying neurological or behavioral component, including indications in psychiatry, neurology, oncology, immunology, and cardiometabolic diseases.
Industry Insights
Where Clinical Trial Activities Meet Digital Therapeutics
With FDA guidance on Prescription Drug Use-Related Software (PDURS), now is the time to expand and enhance treatment options for patients with Digital Therapeutics.
Medidata and Click Therapeutics extend patient engagement beyond the trial, creating lifelong connections from clinical trials to continuous care using DTx.
Interested in learning more? Sign-up to be notified as more information becomes available.